Last edited by Mikarg
Thursday, July 16, 2020 | History

3 edition of SEER, Surveillance, Epidemiology, and End Results Program. found in the catalog.

SEER, Surveillance, Epidemiology, and End Results Program.

SEER, Surveillance, Epidemiology, and End Results Program.

  • 45 Want to read
  • 27 Currently reading

Published by National Institutes of Health, National Cancer Institute in [Bethesda, Md.] .
Written in English

    Subjects:
  • SEER Program (National Cancer Institute (U.S.)),
  • Cancer -- Reporting -- United States,
  • Cancer -- Research -- United States

  • Edition Notes

    SeriesNIH publication -- no. 00-4772.
    ContributionsSEER Program (National Cancer Institute (U.S.)), National Cancer Institute (U.S.)
    The Physical Object
    Pagination8 p. :
    ID Numbers
    Open LibraryOL17595722M
    OCLC/WorldCa44940487

      The Surveillance, Epidemiology, and End Results (SEER) Program, administered by the National Cancer Institute (NCI), has been funded since as a result of the National Cancer Act of SEER collects reportable cancer cases from 20 U.S. geographic areas, including 5 states (see map below).   The study population consisted of patients in the Surveillance, Epidemiology and End Results (SEER) Program database diagnosed with PCa between and Patients were assigned to the following clinical risk groups: low-risk localised (LRL), intermediate-risk localised (IRL), high-risk localised (HRL), node-positive and metastatic (M1).

    The SEER Program is a sequel to two earlier NCI programs, the End Results Program and the Third National Cancer Survey. Case ascertainment and data collection for the SEER Program began with January 1, diagnoses in several geographic areas . External validation of the 8th Edition Melanoma Staging System of the American Joint Committee on Cancer (AJCC) using the surveillance, epidemiology and end results (SEER) program A Tjokrowidjaja Medical Oncology, St George Hospital, Kogarah, Australia.

    An overview of data on cancer at all sites combined and on selected, frequently occurring cancers is presented. Descriptive cancer statistics include average annual Surveillance, Epidemiology, and End Results (SEER) Program incidence, U.S. mortality and median age at diagnosis, and death for the period – Surveillance, Epidemiology, and End Results (SEER) Program. The NCI-funded SEER Program was established in and is a population-based surveillance system that collects data from various cancer registries. SEER is an authoritative source of information on cancer incidence and survival in the United States.


Share this book
You might also like
Complex bundling networks and new-generation terminals

Complex bundling networks and new-generation terminals

concise bibliography on Zionism & Palestine.

concise bibliography on Zionism & Palestine.

COUPLING PROCESSES BETWEEN ATMOSPHERIC CHEMISTRY AND CLIMATE SEMIANNUAL REPORT... NASA/CR-1998-207434... MAY 5, 1998.

COUPLING PROCESSES BETWEEN ATMOSPHERIC CHEMISTRY AND CLIMATE SEMIANNUAL REPORT... NASA/CR-1998-207434... MAY 5, 1998.

Jewish life in modern times

Jewish life in modern times

Workbooks Single Image #12 (Single Image)

Workbooks Single Image #12 (Single Image)

Mountains and volcanoes.

Mountains and volcanoes.

Listen to the Lord

Listen to the Lord

Observers world airlines and airliners directory

Observers world airlines and airliners directory

Money and banking in the United States

Money and banking in the United States

Accounts 2001-2002

Accounts 2001-2002

Trance Warriors

Trance Warriors

All about Bury

All about Bury

Ships Fire-Fighting Manual

Ships Fire-Fighting Manual

SEER, Surveillance, Epidemiology, and End Results Program Download PDF EPUB FB2

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).

InCongress passed SEER National Cancer Act, external icon which mandated the collection, analysis, and dissemination of data useful for the prevention, diagnosis, and treatment of cancer.

This mandate led to the establishment of the National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) SEER.

external icon 1. SEER Cancer Statistics, Age-Specific SEER Incidence Rates, The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute (NCI) is a source of epidemiologic information on the incidence and survival rates of cancer in the United States.

NCI's Surveillance, Epidemiology, and End Results (SEER) program provides information on cancer statistics that underpins efforts to reduce the cancer burden among the U.S. population. Learn more about the SEER program. SEER is supported by the Surveillance Research Program (SRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS).

SRP provides national leadership in the science of cancer surveillance as well as analytical tools and methodological expertise in collecting, analyzing, interpreting, and disseminating reliable population-based.

Visit the SEER Training Website to access web-based training modules for cancer registration and surveillance. The training modules on this site are funded by the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program.

The Surveillance, Epidemiology and End Results (SEER) database was analyzed for patients diagnosed with Wilms' tumor between and Patients were stratified into pediatric (RESULTS.

Guidelines, tools, and resources for cancer registrars, including coding and staging manuals, glossary, drug database (SEER*Rx), SEER abstracting tool (SEER*Abs), Q&A resources, and training modules for registration and surveillance.

Also read SEER. NIH RFQ: Surveillance Epidemiology and End Results (SEER) Electronic Data Capture Software Support and Installations. Jackie Gilbert - renewal of all existing site licenses previously purchased by the National Cancer Institute and installed within SEER Program.

To explore the Surveillance, Epidemiology, and End Results 18 (SEER 18) database to determine the epidemiology of PCNSTCL. Methods The SEER 18 registry database was queried to identify patients diagnosed with PCNSTCL from to and extract their information.

Primary central nervous system T-cell lymphoma (PCNSTCL) is a rare neoplasm with few data regarding its common features and survival characteristics.T. This study evaluated patients registered with the Surveillance, Epidemiology, and End Results (SEER) program who were diagnosed with a primary angiosarcoma of the head and neck region.

The SEER program of the National Cancer Institute is a. Glioma cases from the general population were identified from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program. SEER cases were matched to ACTUR cases by age, sex, race, histology, and diagnosis year.

All cases had histologically confirmed glioma diagnosed between January 1,and December Statistical reports from the Surveillance, Epidemiology, and End Results (SEER) Program are frequently consulted for information on patient survival ().Although informative, these reports generally provide information by stage, age group, and/or calendar year, and the statistic provided is relative survival, which does not account for competing causes of death.

SEER (Surveillance, Epidemiology, and End Results Program) Source: Surveillance and Operations Research Branch, Blair Building, RoomNational Cancer Institute (NCI), National Institutes of Health, Bethesda, MDCited by:   This work was supported by the Kaplan Cancer Research Fund, the Metastatic Breast Cancer Alliance, and the Surveillance, Epidemiology, and End Results (SEER) Cancer Surveillance System (CSS) program of the National Cancer Institute (contract HHSNI; National Cancer Institute control number N01 PC‐‐) for.

The limited information available on the tumor represents a challenge in both diagnosis and subsequent management. Here, we present characteristics of patients diagnosed with astroblastomas using the Surveillance, Epidemiology, and End Results (SEER.

Results: We included patients after application of inclusion and exclusion criteria. The mean patient age was ± years, and the cohort was % male. Overall median survival was 12 months, with notable improvement over the last 3 decades.

Surveillance, Epidemiology, and End Results (SEER) data indicate age-adjusted incidence rates of to perpersons in the United States. The incidence tripled from toand approximately cases of MCC are diagnosed each year.

– MCC is rare in blacks; most patients are white (%). Ninety percent of. The Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute collects data on cancer diagnoses, treatment, and survival for approximately 30% of the United States (US) population.

Tan, J. (). Surveillance, epidemiology and end results program (seer). In Y. Zhang (Ed.), Encyclopedia of global health (Vol.

1, pp. ). Thousand Oaks, CA.Background: Male breast cancer is rare and understudied compared with female breast cancer. A current comparison with female breast cancer could assist in bridging this gap. Although conflicting data have been reported on male and female survival outcomes, data from through in the Surveillance, Epidemiology, and End Results (SEER) program have.

Cancer diagnosis data for – and follow-up data to from nine population-based registries, part of the NCI Surveillance, Epidemiology, and End Results (SEER) program. PARTICIPANTS Approximately million patients from SEER registries diagnosed with cancer of the colon/rectum, breast, prostate, lung, liver, pancreas, or ovary.